Intellectual rights for HIV blockbuster drug from Gilead threatened by Teva

Top-selling antiretroviral HIV drug from Gilead, Truvada, is being challenged by Teva for patent rights by Caroline A. Falciola, PhD , 17/11/2008

The Phamaceutical Biomanufacturing Industry: a growing sector!

Contract biomanufacturing is a significant market estimated at Euro 2.3 billion this year with an annual growth of about 10 to 15%. by Philippe Tramoy , 15/09/2008

Review of the The Enzyme Market

The enzyme market is a significant market estimated at EUR 3.4 billion with an annual growth of about 6.5 to 10%. Enzymes are sold in many different industry segments. These segments are Detergents, Food, Feed, Technical, Pharmaceutical, Microorganisms and Biofuels... 14/07/2008

New Frontiers In Medicine: RNAi Therapeutics

The discovery of RNA interference (RNAi) represents a unique milestone in biology and opens the way for innovative applications in pharmaceutical science and therapy. 08/02/2008

Addiction Management... a Long and Bumpy Road

13.09.2007